MaxCyte, Inc. (NASDAQ:MXCT – Free Report) shares were up 7.1% on Monday . The stock traded as high as $4.96 and last traded at $4.96. Approximately 134,093 shares traded hands during mid-day trading, a decline of 74% from the average daily volume of 514,905 shares. The stock had previously closed at $4.63. Wall Street Analyst […]
Gagnon Securities LLC acquired a new stake in MaxCyte, Inc. (NASDAQ:MXCT – Get Rating) in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm acquired 34,468 shares of the company’s stock, valued at approximately $188,000. Several other hedge funds have also recently bought and sold shares of […]
MaxCyte, Inc. (NASDAQ:MXCT – Get Rating) EVP Thomas M. Ross sold 6,967 shares of the stock in a transaction dated Wednesday, April 5th. The stock was sold at an average price of $5.00, for a total transaction of $34,835.00. The transaction was disclosed in a legal filing with the SEC, which is available through this […]
MaxCyte, Inc. (NASDAQ:MXCT – Get Rating) EVP Thomas M. Ross sold 2,607 shares of MaxCyte stock in a transaction on Friday, March 31st. The stock was sold at an average price of $5.00, for a total transaction of $13,035.00. Following the transaction, the executive vice president now directly owns 333,197 shares in the company, valued […]